Canada markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
138.73+2.53 (+1.86%)
At close: 01:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 211.02B
Enterprise Value 233.78B
Trailing P/E 35.75
Forward P/E 16.16
PEG Ratio (5 yr expected) 0.87
Price/Sales (ttm)4.64
Price/Book (mrq)5.39
Enterprise Value/Revenue 5.10
Enterprise Value/EBITDA 17.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3-11.04%
S&P500 52-Week Change 320.07%
52 Week High 3153.10
52 Week Low 3118.16
50-Day Moving Average 3131.37
200-Day Moving Average 3132.54

Share Statistics

Avg Vol (3 month) 33.01k
Avg Vol (10 day) 31.12k
Shares Outstanding 51.55B
Implied Shares Outstanding 61.57B
Float 81.54B
% Held by Insiders 10.23%
% Held by Institutions 150.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.86
Forward Annual Dividend Yield 42.10%
Trailing Annual Dividend Rate 32.90
Trailing Annual Dividend Yield 32.13%
5 Year Average Dividend Yield 42.50
Payout Ratio 475.49%
Dividend Date 3Sept 09, 2019
Ex-Dividend Date 4Feb 22, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin 13.00%
Operating Margin (ttm)16.92%

Management Effectiveness

Return on Assets (ttm)6.60%
Return on Equity (ttm)15.64%

Income Statement

Revenue (ttm)45.81B
Revenue Per Share (ttm)29.58
Quarterly Revenue Growth (yoy)7.30%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)5.95B
Diluted EPS (ttm)3.81
Quarterly Earnings Growth (yoy)6.50%

Balance Sheet

Total Cash (mrq)5.86B
Total Cash Per Share (mrq)3.78
Total Debt (mrq)29.65B
Total Debt/Equity (mrq)75.70%
Current Ratio (mrq)0.82
Book Value Per Share (mrq)25.25

Cash Flow Statement

Operating Cash Flow (ttm)10.34B
Levered Free Cash Flow (ttm)9.5B